GGrantIndex
Sort

3,198 grants matching mrna vaccine

COVID vaccine-associated allergic reactions

$35,184
Pamela Guerrerio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

IGF::OT::IGF YT 16-107 - RESEARCH, DEV., AND PROD., OF MRNA VACCINE ANTIGENS

$35,050
Chris Case · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA

Nipah virus vaccines and monoclonal antibodies

$34,822
Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

The Role of miRNA in Dendritic Cell Function

$34,663
Gregory Mullokandov · Icahn School Of Medicine At Mount Sinai · F30 · FY2014 · HL

T lymphocyte bystander responses in male-biased myocarditis

$34,522
Anis Barmada · Yale University · F30 · FY2025 · AI

Function of mRNA Editing in Trypanosomes

$34,452
Stephen L Hajduk · University Of Georgia · R01 · FY2009 · AI

The Role of miRNA in Dendritic Cell Function

$34,219
Gregory Mullokandov · Icahn School Of Medicine At Mount Sinai · F30 · FY2013 · HL

Elicitation of broad immunity using VLPs with consensus envs

$33,809
Ted M Ross · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · AI

Engineering bacterial group I introns for efficient production of safe and durable nucleoside-modified circular mRNA therapeutics

$33,780
Alejandro Felix Mejia · Univ Of Massachusetts Med Sch Worcester · F31 · FY2025 · GM

CANCER EPIDEMIOLOGY PROGRAM

$33,558
Thomas E Rohan · Albert Einstein College Of Medicine · P30 · FY2011 · CA

Novel Dendritic Cell Chemoattractant and Receptor

$33,166
Eugene C Butcher · Stanford University · R01 · FY2007 · AI

CANCER EPIDEMIOLOGY PROGRAM

$33,078
Thomas E Rohan · Albert Einstein College Of Medicine · P30 · FY2010 · CA

Characterizing the Genomic Basis of Immune-Mediated Resilience Against Tuberculosis in an Admixed Peruvian Population

$32,875
Laurie Ann Rumker · Harvard Medical School · F30 · FY2022 · AI

ENTEROVIRUS 71 LEADER: TARGET FOR PEPTIDE INHIBITORS

$32,416
Stanford University · F32 · FY2000 · AI

An integrative approach to identify neuroblastoma immunotherapeutic targets

$32,081
Amber Hamilton · University Of Pennsylvania · F31 · FY2019 · CA

Genome Structure, Transcription and Packaging of dsRNA Viruses

$31,788
Z Hong Zhou · University Of California Los Angeles · R01 · FY2023 · AI

The Role of Group 2 Innate Lymphoid Cells in RSV-Induced Airway Dysfunction

$29,889
Matthew T. Stier · Vanderbilt University · F30 · FY2016 · AI

The Role of Group 2 Innate Lymphoid Cells in RSV-Induced Airway Dysfunction

$29,433
Matthew T. Stier · Vanderbilt University · F30 · FY2015 · AI

The Role of Group 2 Innate Lymphoid Cells in RSV-Induced Airway Dysfunction

$28,989
Matthew T. Stier · Vanderbilt University · F30 · FY2014 · AI

Rapidly Degraded Polypeptides in Protein Quality Control

$28,853
Joshua Rene Lacsina · Duke University · F31 · FY2008 · GM

Cellular RNA binding and regulation by NFX1-123 and its perturbation by high risk human papillomavirus E6

$28,450
Rachel Adria Katzenellenbogen · Seattle Children'S Hospital · R21 · FY2018 · AI

Primary hepatocyte and engineered iPSC-derived hepatocyte-like cell transplantation to treat alpha-1 antitrypsin deficiencyassociated liver disease

$27,783
Anna R. Smith · Boston University Medical Campus · F31 · FY2024 · DK

An integrative approach to identify neuroblastoma immunotherapeutic targets

$27,462
Amber Hamilton · University Of Pennsylvania · F31 · FY2020 · CA

Novel organic-ion-based technology for long-term virus preservation at ambient temperature

$27,344
Arsalan Mirjafari · Florida Gulf Coast University · R21 · FY2022 · GM

Infection and Rapid Transmission of SARS-C0V-2 in Ferrets

$26,293
Jae U Jung · University Of Southern California · R01 · FY2020 · AI